Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe Gulliver

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Future Science OA|January 13, 2021
The enigmatic helicase DHX9 and its association with the hallmarks of cancerChloe Gulliver, Ralf Hoffmann, George S Baillie
The International Journal of Biochemistry & Cell Biology|May 24, 2022
Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancerChloe Gulliver, Ralf Hoffmann, George S Baillie
Future Science OA|September 27, 2023
Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding regionChloe Gulliver, George S Baillie, Ralf Hoffmann
British Journal of Cancer|September 22, 2023
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategiesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Cancers|January 8, 2023
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology OutcomesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Molecular Oncology|December 21, 2023
cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progressionChloe Gulliver, Tara Busiau, Ashleigh Byrne, et al.
Nucleic Acids Research|August 21, 2025
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome armsAnna Oncins, Roser Zaurin, Houyem Toukabri, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Future Science OA|January 13, 2021
The enigmatic helicase DHX9 and its association with the hallmarks of cancerChloe Gulliver, Ralf Hoffmann, George S Baillie
The International Journal of Biochemistry & Cell Biology|May 24, 2022
Ataxia-telangiectasia mutated and ataxia telangiectasia and Rad3-related kinases as therapeutic targets and stratification indicators for prostate cancerChloe Gulliver, Ralf Hoffmann, George S Baillie
Future Science OA|September 27, 2023
Reduced PDE4D7 in prostate cancer correlates with genomic downregulation within the upstream PDE4D coding regionChloe Gulliver, George S Baillie, Ralf Hoffmann
British Journal of Cancer|September 22, 2023
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategiesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Cancers|January 8, 2023
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology OutcomesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Molecular Oncology|December 21, 2023
cAMP-phosphodiesterase 4D7 (PDE4D7) forms a cAMP signalosome complex with DHX9 and is implicated in prostate cancer progressionChloe Gulliver, Tara Busiau, Ashleigh Byrne, et al.
Nucleic Acids Research|August 21, 2025
Translocations can drive expression changes of multiple genes in regulons covering entire chromosome armsAnna Oncins, Roser Zaurin, Houyem Toukabri, et al.
Pageof 1